News Quantified

EQ – equillium, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Equillium (NASDAQ:EQ) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

Equillium to Participate in Upcoming Investor Conferences [Yahoo! Finance]

Equillium to Participate in Upcoming Investor Conferences

-37.4%

BEAT

Form SCHEDULE 13G/A Equillium, Inc. Filed by: JANUS HENDERSON GROUP PLC

Form 4 Equillium, Inc. For: Jan 07 Filed by: Connelly Stephen

Form 4 Equillium, Inc. For: Jan 07 Filed by: Zedelmayer Christine

Form 4 Equillium, Inc. For: Jan 07 Filed by: Steel Bruce D.

Form 4 Equillium, Inc. For: Jan 07 Filed by: Tom Penny

Top News Gainers

3/18 Equillium (NYSE: EQ) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 33.1%

12/9 Equillium Granted U.S. FDA Fast Track Designation for Itolizumab for the Treatment of Lupus Nephritis 17.3%

11/13 Form S-3 Equillium, Inc. 13.4%

1/24 Biocon Ltd. ADR (BCNQY) CEO Siddharth Mittal on Q3 2020 Results - Earnings Call Transcript [Seeking Alpha] 8.7%

1/2 Form 3 Equillium, Inc. For: Jan 01 Filed by: Zedelmayer Christine 7.6%

8/12 Q2/2019 6/30/2019 EPS -0.350 ZacksConsensus -0.340 ActVsEst (0.010) - Miss 5.6%

12/12 Form 4 Equillium, Inc. For: Dec 10 Filed by: Connelly Stephen 5.3%

3/30 Equillium Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital 4.2%

11/7 Equillium to Present at Investor Conferences in November 2019 4.0%

8/15 Equillium (NYSE: EQ) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $4.00 price target on the stock. 3.6%

Top News Decliners

12/31 Equillium (NYSE: EQ) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock. -19.3%

8/5 Form 4 Equillium, Inc. For: Aug 01 Filed by: Keyes Jason A -17.3%

12/23 Hedge Funds Are Dumping Equillium, Inc. (EQ) [Yahoo! Finance News] -12.4%

11/15 Equillium Featured in Panel Discussion at Capital Markets Day for Kidney Health -8.1%

12/10 MDB, GNW among premarket gainer [Seeking Alpha] -8.0%

11/12 Q3/2019 9/30/2019 EPS -0.350 ZacksConsensus N/A ActVsEst N/A - N/A -7.5%

2/27 Equillium Strengthens Leadership Team with Key Appointments -5.5%

9/17 Equillium to Host Business Update Call on October 1, 2019 -4.7%

1/29 Equillium to Present Translational Preclinical Data Demonstrating Increased Survival and Decreased Disease Severity in Models of Graft-Versus-Host Disease Treated with Itolizumab at the Transplantation & Cellular Therapy Meetings of ASTCT & CIBMTR -4.4%

3/26 Q4/2019 12/31/2019 EPS -0.440 ZacksConsensus -0.400 ActVsEst (0.040) - Miss -4.4%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day